Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Sarcoma 1Myeloid 1Lymphoid 1Head & Neck 1Genitourinary 1CNS 1

Conditions

Myelodysplastic Syndromes 7Leukemia, Myeloid, Acute 5Leukemia 3Urologic Neoplasms 1Thyroid Neoplasms 1Soft Tissue Neoplasms 1Sarcoma 1Recurrence 1Pharyngeal Neoplasms 1Neurofibromatosis 2 1Neoplasms, Mesothelial 1Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lymphangioleiomyomatosis 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hodgkin Disease 1Hematologic Neoplasms 1Erdheim-Chester Disease 1Endocrine Gland Neoplasms 1Castleman Disease 1Carcinoma, Transitional Cell 1Breast Neoplasms 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Therapeutics 6Flow Cytometry 5Psychiatric Rehabilitation 3Immunologic Techniques 3Cyclophosphamide 3Amplified Fragment Length Polymorphism Analysis 3ruxolitinib 2pembrolizumab 2liposomal amphotericin B 2abiraterone 2Vorinostat 2Sirolimus 2Radiotherapy 2Polymerase Chain Reaction 2Ondansetron 2Mycophenolic Acid 2Methylprednisolone 2Itraconazole 2Ipilimumab 2Immunoglobulin G 2Immunoenzyme Techniques 2Gemcitabine 2Doxorubicin 2Disulfides 2Dexamethasone 2Deferasirox 2Caspofungin 2Calcium Dobesilate 2CTLA-4 Antigen 2Bevacizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Valproic Acid × Myeloid × Clear all
NCT01552434 2026-05-15

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

M.D. Anderson Cancer Center

Phase 1 Terminated
154 enrolled
BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡